Becton Dickinson Pre-Paid Expenses 2010-2024 | BDX
Becton Dickinson pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
- Becton Dickinson pre-paid expenses for the quarter ending September 30, 2024 were $1.018B, a 20.59% decline year-over-year.
- Becton Dickinson pre-paid expenses for 2023 were $1.38B, a 11.48% decline from 2022.
- Becton Dickinson pre-paid expenses for 2022 were $1.559B, a 48.76% increase from 2021.
- Becton Dickinson pre-paid expenses for 2021 were $1.048B, a 17.62% increase from 2020.
Becton Dickinson Annual Pre-Paid Expenses
(Millions of US $) |
| 2023 |
$1,380 |
| 2022 |
$1,559 |
| 2021 |
$1,048 |
| 2020 |
$891 |
| 2019 |
$1,119 |
| 2018 |
$1,251 |
| 2017 |
$871 |
| 2016 |
$480 |
| 2015 |
$563 |
| 2014 |
$698 |
| 2013 |
$623 |
| 2012 |
$515 |
| 2011 |
$631 |
| 2010 |
$410 |
| 2009 |
$376 |
Becton Dickinson Quarterly Pre-Paid Expenses
(Millions of US $) |
| 2024-06-30 |
$1,018 |
| 2024-03-31 |
$1,330 |
| 2023-12-31 |
$1,349 |
| 2023-09-30 |
$1,380 |
| 2023-06-30 |
$1,282 |
| 2023-03-31 |
$1,444 |
| 2022-12-31 |
$1,545 |
| 2022-09-30 |
$1,559 |
| 2022-06-30 |
$1,392 |
| 2022-03-31 |
$1,256 |
| 2021-12-31 |
$1,040 |
| 2021-09-30 |
$1,048 |
| 2021-06-30 |
$1,207 |
| 2021-03-31 |
$1,065 |
| 2020-12-31 |
$889 |
| 2020-09-30 |
$891 |
| 2020-06-30 |
$903 |
| 2020-03-31 |
$1,156 |
| 2019-12-31 |
$987 |
| 2019-09-30 |
$1,119 |
| 2019-06-30 |
$1,326 |
| 2019-03-31 |
$1,161 |
| 2018-12-31 |
$1,157 |
| 2018-09-30 |
$1,251 |
| 2018-06-30 |
$1,196 |
| 2018-03-31 |
$1,241 |
| 2017-12-31 |
$1,255 |
| 2017-09-30 |
$871 |
| 2017-06-30 |
$731 |
| 2017-03-31 |
$664 |
| 2016-12-31 |
$643 |
| 2016-09-30 |
$480 |
| 2016-06-30 |
$409 |
| 2016-03-31 |
$551 |
| 2015-12-31 |
$514 |
| 2015-09-30 |
$563 |
| 2015-06-30 |
$921 |
| 2015-03-31 |
$1,016 |
| 2014-12-31 |
$784 |
| 2014-09-30 |
$698 |
| 2014-06-30 |
$649 |
| 2014-03-31 |
$678 |
| 2013-12-31 |
$650 |
| 2013-09-30 |
$623 |
| 2013-06-30 |
$472 |
| 2013-03-31 |
$467 |
| 2012-12-31 |
$438 |
| 2012-09-30 |
$515 |
| 2012-06-30 |
$565 |
| 2012-03-31 |
$630 |
| 2011-12-31 |
$600 |
| 2011-09-30 |
$631 |
| 2011-06-30 |
$571 |
| 2011-03-31 |
$512 |
| 2010-12-31 |
$415 |
| 2010-09-30 |
$410 |
| 2010-06-30 |
$385 |
| 2010-03-31 |
$373 |
| 2009-12-31 |
$359 |
| 2009-09-30 |
$376 |
| 2009-06-30 |
$357 |
| 2009-03-31 |
$435 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.352B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
